Sarcoidosis is a granulomatous disorder of unknown etiology that affects multiple organs. Sarcoidosis seems to result from the exposure of a genetically susceptible subject to an environmental agent, and microbial etiologies of sarcoidosis have long been considered based on the clinical similarities to infectious granulomatous diseases.^[@bib1]^ Several epidemiological mechanisms may underlie the association of an infective agent or agents with the etiology of sarcoidosis, including spatial, seasonal, and occupational clustering.^[@bib2]^ Data from the completed ACCESS (A Case Control Etiologic Study of Sarcoidosis) study support possible disease associations with selected microbially-rich environments.^[@bib3]^

Mycobacterial and propionibacterial organisms are most commonly implicated as potential etiologic agents based on studies using polymerase chain reaction (PCR) methods that report the detection of microbial DNA from these organisms in tissues from sarcoid patients around the world.^[@bib4],\ [@bib5],\ [@bib6]^ The results from different studies have varied considerably, however, with reports of microbial DNA in 0--80% of sarcoidosis tissues as well as in 0% to more than 30% of control tissues.^[@bib7],\ [@bib8]^ The failure to detect microbial DNA from these organisms in samples from some sarcoid patients suggests other causes of sarcoidosis in those patients, whereas the detection of microbial DNA in some control samples suggests latent infection of the bacterium.

Immune responses against microbial antigens from these organisms, such as ESAT-6 and KatG peptides from *Mycobacterium tuberculosis* and a recombinant trigger-factor protein from *P.. acnes*, have been examined in sarcoid patients and control subjects.^[@bib9],\ [@bib10]^ Although immune responses are frequently detected in sarcoid patients, such immune responses are also sometimes detected in non-sarcoid patients or healthy subjects. Latent infection of these organisms has complicated interpretation of the results from these immunological studies. Unless microbial antigens that cause a specific immune response found only in sarcoid patients can be used to stimulate an immune response, immunological approaches will not be sufficient to unequivocally confirm that these organisms are causative.

Granulomas usually form as a result of the persistence of a nondegradable product or as the result of hypersensitivity responses.^[@bib11]^ An overlap of the two mechanisms occurs in most infectious diseases because microorganisms can serve both as foreign bodies and as antigens for immunological responses. Normally, granulomas are the result of protective mechanisms by which the invading agent is sequestered and further degraded. Given that an epithelioid cell granuloma is the pathological hallmark of sarcoidosis, any etiologic agent of sarcoidosis must be present or have been present within sarcoid granulomas. Therefore, histopathological studies to demonstrate mycobacterial or propionibacterial organisms or antigens within sarcoid granulomas are essential to prove an etiologic link between sarcoidosis and these organisms.

To date, *P. acnes* is the only microorganism that has been isolated from sarcoid lesions by bacterial culture.^[@bib12]^ This indigenous bacterium was isolated from 78% of biopsied lymph nodes of Japanese patients with sarcoidosis.^[@bib13]^ In the present study, we used immunohistochemical approaches to test the hypothesis that *P. acnes* is an etiologic agent of sarcoidosis. To locate *P. acnes* in routine histological sections, we developed *P. acnes*-specific monoclonal antibodies that react with this bacterium in formalin-fixed and paraffin-embedded tissue sections by immunizing mice with *P. acnes* or a recombinant trigger-factor protein from the bacterium. To elucidate an etiologic link between sarcoidosis and *P. acnes*, we examined the frequency of *P. acnes* found within sarcoid granulomas of the lungs and lymph nodes by immunohistochemistry with the novel antibodies. We also examined corresponding control samples from patients with diseases other than sarcoidosis to search for possible latent infection by the bacterium.

Materials and methods
=====================

Samples
-------

We examined formalin-fixed and paraffin-embedded tissue sections of biopsy and surgical samples of the lungs (77 samples) and lymph nodes (119 samples) from 196 patients with sarcoidosis, together with corresponding control samples (110 lung and 165 lymph node samples) from 275 patients with diseases other than sarcoidosis. These tissue sections were obtained from the archives of the Tokyo Medical and Dental University, Japan Red Cross Medical Center, and Ruhrlandklinik in Essen, Germany. The diagnosis of sarcoidosis was based on the clinical picture, no evidence of current infection by *M. tuberculosis* or other organisms known to produce granulomatous diseases, and the presence of noncaseating granulomas in biopsy or surgical specimens of involved tissues, according to the statement published in 1999.^[@bib1]^ Lung and lymph node samples from patients with tuberculosis or sarcoid reaction were used as non-sarcoid granulomatous lesions owing to the abundance of samples available for the study. Diagnosis of tuberculosis was based on the clinical picture, successful identification of *M. tuberculosis* by culture or Ziehl--Neelsen stain, and the presence of caseating epithelioid cell granulomas in the involved tissues. Patients with sarcoid reaction were defined as individuals without any symptoms or signs of systemic sarcoidosis who showed noncaseating epithelioid cell granulomas in lymph nodes draining a region housing a malignant tumor (lung, gastric, or colorectal cancer) or in the primary tumor itself.^[@bib14]^ Lung samples from patients with idiopathic interstitial pneumonia or chronic hypersensitivity pneumonitis and lymph node samples from patients with reactive or necrotizing lymphadenitis were used as non-sarcoid inflammatory lesion samples. Cancer-free lung tissues from patients with lung cancer and cancer-free regional lymph nodes from patients with lung, gastric, or colorectal cancer were used as normal control tissues. The diagnosis of disease was established in each hospital and histologically reconfirmed by some of the authors before the study. This study was approved by the ethics committees of the three institutes from which the samples were obtained.

Production of Monoclonal Antibodies
-----------------------------------

Novel monoclonal antibodies were developed to locate *P. acnes* in formalin-fixed and paraffin-embedded tissue sections. Antibodies were generated according to the protocol described in a laboratory manual^[@bib15]^ with modifications. BALB/c mice (CLEA Japan, Tokyo, Japan) were immunized with sonicated whole bacterial lysate of *P. acnes* (ATCC 11828) or a recombinant trigger-factor protein from *P. acnes* that was constructed using the full sequence of the gene.^[@bib10],\ [@bib16]^ Hybridoma cell lines producing anti-*P. acnes* antibodies or anti-trigger-factor protein antibodies were checked by enzyme-linked immunosorbent assay with the bacterial antigens or the trigger-factor protein used as immunogens. Hybridoma cell lines with positive results were screened by immunohistochemistry with formalin-fixed and paraffin-embedded tissue sections of *P. acnes*-injected rat liver. *P. acnes*-injected rat liver was obtained by intravenous injection of 30 mg of heat-killed *P. acnes* into female Sprague--Dawley rats (CLEA Japan) 1 h before killing the rat. Similarly-prepared liver tissue sections of rats injected by each strain of other control bacteria were also examined to confirm the specificity to *P. acnes*. Hybridoma cell lines producing the antibody that generated a strong reaction specific to *P. acnes* on rat liver sections were selected and further screened by immunohistochemistry with formalin-fixed and paraffin-embedded tissue sections of sarcoid lymph nodes in which a large number of *P. acnes* genomes were detected in a previous study.^[@bib17]^ The hybridoma producing the antibody that generated the most specific reaction product on human tissue sections was selected and cloned by two rounds of limiting dilution. A single hybridoma clone was then implanted into the intraperitoneal space of severe combined immunodeficiency mice (CLEA Japan). At 1 or 2 weeks after implantation, ascites was collected and used as an undiluted antibody without further purification. The antibody obtained by immunization of the bacterial lysate was named PAB antibody (IgM, κ) and the antibody obtained by immunization of the recombinant trigger-factor protein was named TIG antibody (IgG, λ) in the present study.

Immunohistochemistry
--------------------

Histological sections (4 *μ*m-thick) were cut from formalin-fixed and paraffin-embedded tissue samples and mounted on silane-coated slides (Muto Pure Chemicals, Tokyo, Japan). After the sections were de-paraffinized and rehydrated, they were microwaved (Microwave Processor H2850; Energy Beam Sciences, East Granby, CT, USA) in 10 mmol/l citrate buffer (pH 6.0) for 40 min at 97 °C. The sections were then treated with 3% hydrogen peroxide in methanol for 10 min. The sections were first incubated with normal horse serum (Vectastain Universal Elite ABC Kit; Vector Laboratories, Burlingame, CA, USA) and then incubated overnight at room temperature with one of the appropriately diluted antibodies (PAB antibody 1:15 000 and TIG antibody 1:8000) in a humidified chamber. The sections were then incubated for 30 min with biotinylated secondary antibody, followed by 30-min incubation with streptavidin--peroxidase complex (Vectastain Universal Elite ABC Kit), both at room temperature. Before and after each step, the sections were washed in phosphate-buffered saline containing 0.5% Tween-20. The signal was developed as a brown reaction product using peroxidase substrate diaminobenzidine (Histofine Simplestain DAB Solution; Nichirei Bioscience, Tokyo, Japan). All specimens were counterstained with Mayer\'s hematoxylin. Adjacent histological sections were also examined with hematoxylin and eosin staining as well as Fite staining for acid-fastness.^[@bib18]^

Immunofluorescence Double-Staining
----------------------------------

According to the methods described previously,^[@bib19]^ formalin-fixed and paraffin-embedded tissue sections of sarcoid lymph nodes with many *P. acnes*-positive cells were used for immunofluorescence double-staining to phenotype the cells with intracellular *P. acnes* using the antibodies to phagocytes, anti-human CD68 monoclonal antibody (clone KP1; DAKO) for macrophages, and anti-human fascin monoclonal antibody (clone 55K-2; DAKO) for dendritic cells.

Immunoelectron Microscopy
-------------------------

Formalin-fixed paraffin-embedded tissue sections of sarcoid lymph nodes with many *P. acnes*-positive cells were used for immunoelectron microscopy with PAB and TIG antibodies according to the previously described methods.^[@bib19]^

Western Blot
------------

The specificity of PAB and TIG antibodies was examined by western blot with ATCC strains and clinical isolates of *P. acnes*, other cutaneous propionibacteria (*P. granulosum*, *P. avidum*, *P. lymphophilum*, and *P. propionicum*), dairy propionibacteria (*P. freudenreichii*, *P. jensenii*, *P. thoenii*, and *P. acidipropionici*), and other control bacteria, including mycobacteria ([Table 1](#tbl1){ref-type="table"}). Three strains of serotype I *P. acnes* (ATCC 6919, ATCC 11827, and clinical isolate S4) and two strains of serotype II *P. acnes* (ATCC 11828 and clinical isolate S7) were used in the study, based on the results of a previous serotyping analysis.^[@bib20]^ Lipoteichoic acid was purified from *P. acnes*, according to the previously described method^[@bib21]^ with modifications. Western blot was performed according to the previously described methods.^[@bib19]^

Statistical Analyses
--------------------

The χ^2^ test for proportion with Yates\' correction was used to evaluate differences in frequency between pairs of groups. Differences with *P* values of \<0.05 were considered statistically significant. StatView software (version 5.0; SAS Institute, Cary, NC, USA) was used for the statistical calculations.

Results
=======

Specificity of Monoclonal Antibodies
------------------------------------

The specificity of PAB and TIG antibodies is shown in [Table 1](#tbl1){ref-type="table"}. These monoclonal antibodies reacted with all strains of *P. acnes*, irrespective of the serotype (I or II), strain type, or clinical isolate, and there was no cross-reactivity with other propionibacteria or the control bacteria. PAB antibody recognized a *P. acnes*-specific epitope of the lipoteichoic acid commonly shared by all strains of this bacterium ([Figure 1](#fig1){ref-type="fig"}). TIG antibody reacted with the recombinant trigger-factor protein from *P. acnes* and two or three protein bands were observed on the membrane with the whole bacterial lysate of this bacterium.

Localization of *P. acnes* Within Sarcoid Granulomas
----------------------------------------------------

In the lungs and lymph nodes, PAB antibody reacted with small round bodies in some of the immature and mature epithelioid cells and multinucleated giant cells of sarcoid granulomas ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). The appearance of the small round bodies detected by PAB antibody within sarcoid granulomas did not differ between lungs and lymph nodes. The amount of these small round bodies varied from each granuloma in identical sarcoid samples as well as from each sarcoid tissue sample. In sarcoid granulomas with many small round bodies, the cytoplasm of some granuloma cells was filled with small round bodies, just like intracellular proliferation of the bacterium ([Figures 2b,d](#fig2){ref-type="fig"} and [3b,d](#fig3){ref-type="fig"}). In many sarcoid granulomas, a few small round bodies were scattered in some of the granuloma cells with occasionally degraded or large-sized features of the bodies ([Figures 2f](#fig2){ref-type="fig"} and [3f](#fig3){ref-type="fig"}).

Detection Frequency of *P. acnes* Within Granulomas
---------------------------------------------------

In the lungs, small round bodies detected by PAB antibody within granulomas were found in 44 (57%) of 77 lung samples from sarcoid patients ([Table 2](#tbl2){ref-type="table"}). The frequency was significantly higher in samples obtained by video-assisted thoracic surgery than in samples obtained by transbronchial lung biopsy (74% *vs* 48%, *P*=0.049). No reactivity was detected within granulomas in any of the lung samples of the 17 patients with tuberculosis or the 10 patients with sarcoid reaction. A few cells with small round bodies were scattered in interstitial inflammatory cells around the sarcoid granulomas of the lungs ([Figure 2d](#fig2){ref-type="fig"}) in 22 (81%) of the surgically-resected samples and 18 (36%) of the biopsy samples from sarcoid patients.

In the lymph nodes, small round bodies detected by PAB antibody within sarcoid granulomas were found in 105 (88%) of 119 lymph node samples ([Table 3](#tbl3){ref-type="table"}). The frequency was not significantly different between samples from Japanese and German patients (88% *vs* 89%, respectively) or between samples of mediastinal and superficial lymph nodes from Japanese patients (86% *vs* 89%, respectively). No reactivity was detected within granulomas in any of the lymph node samples from 28 patients with tuberculosis and 24 patients with sarcoid reaction.

Intracellular *P. acnes* in Nongranulomatous Areas
--------------------------------------------------

Cells with many small round bodies detected by PAB antibody were observed in alveolar spaces of the sarcoid lungs ([Figure 4a](#fig4){ref-type="fig"}) as well as in granuloma-free paracortical areas of sarcoid lymph nodes ([Figure 4c](#fig4){ref-type="fig"}). Most alveolar and paracortical cells with such small round bodies were stained with the anti-CD68 antibody, but not with the anti-fascin antibody ([Figure 5a--d](#fig5){ref-type="fig"}).

In the lungs, alveolar macrophages with many small round bodies detected by PAB antibody were found in 28 (36%) of 77 sarcoid samples and 18 (16%) of 110 non-sarcoid samples ([Figure 4b](#fig4){ref-type="fig"}; [Table 2](#tbl2){ref-type="table"}). The frequency was significantly higher in sarcoid samples (*P*=0.0031). Such alveolar macrophages occasionally contained one or a few large spheroidal bodies detected by PAB antibody ([Figure 4e](#fig4){ref-type="fig"}) that were acid-fast with Fite staining and also reacted with the TIG antibody ([Figure 4f](#fig4){ref-type="fig"}).

In the lymph nodes, paracortical macrophages with many small round bodies detected by PAB antibody were observed in 26 (22%) of 119 sarcoid samples and 18 (11%) of 165 non-sarcoid samples ([Figure 4d](#fig4){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). The frequency was significantly higher in the sarcoid samples (*P*=0.019).

Hamazaki--Wesenberg Bodies in the Lymph Nodes
---------------------------------------------

In the lymph nodes, large spheroidal bodies detected by PAB antibody were observed in sinus macrophages stained with the anti-CD68 antibody but not in dendritic cells stained with the anti-fascin antibody ([Figure 5e--f](#fig5){ref-type="fig"}), in 60 (50%) of 119 sarcoid samples and in 24 (15%) of 165 non-sarcoid samples ([Figure 6c](#fig6){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). The frequency was significantly higher in sarcoid samples (*P*\<0.001). The large spheroidal bodies detected by PAB antibody in sinus macrophages were yellow--brown in color with hematoxylin and eosin staining and strongly acid-fast with Fite staining ([Figure 6a](#fig6){ref-type="fig"}), consistent with so-called Hamazaki--Wesenberg bodies ([Figure 6b](#fig6){ref-type="fig"}). Most of the Hamazaki--Wesenberg bodies detected by PAB antibody also reacted with the TIG antibody ([Figure 6e](#fig6){ref-type="fig"}), although the TIG antibody did not react with small round bodies detected by PAB antibody in granuloma cells or paracortical macrophages. Immunoelectron microscopy revealed that cell membrane-bound lipoteichoic acid detected by PAB antibody was confined to the outer margins of the Hamazaki--Wesenberg bodies ([Figure 6d](#fig6){ref-type="fig"}), and the ribosome-bound trigger factor detected by TIG antibody was scattered throughout the inner areas of the bodies ([Figure 6f](#fig6){ref-type="fig"}). Electron microscopic analysis revealed that Hamazaki--Wesenberg bodies in the sarcoid lymph nodes lacked a cell-wall structure with occasional protrusions from the body ([Figure 7](#fig7){ref-type="fig"}).

Correlation between Detection of *P. acnes* in Granulomas and in Nongranulomatous Areas
---------------------------------------------------------------------------------------

In all seven sarcoid lung samples obtained by video-assisted thoracic surgery in which no PAB antibody reactivity was observed within the granulomas, PAB antibody reactivity was also totally absent in nongranulomatous areas, including alveolar macrophages ([Table 4](#tbl4){ref-type="table"}). Similarly, PAB antibody reactivity was not observed in nongranulomatous areas in 23 (88%) of the 26 sarcoid samples obtained by transbronchial lung biopsy with no PAB antibody reactivity within the granulomas.

The same association as in the lung samples was found in sarcoid lymph node samples from Japanese and German patients ([Table 4](#tbl4){ref-type="table"}). PAB antibody reactivity in paracortical macrophages was not observed in any of the 4 German or 10 Japanese lymph node samples with no PAB antibody reactivity within the granulomas. Hamazaki--Wesenberg bodies detected by PAB antibody were not found in any of the German samples or in 8 (80%) of the Japanese samples with no PAB antibody reactivity within the granulomas.

Discussion
==========

Granuloma formation is a critical step in the delayed immune response that stops the spread of noxious and infectious microorganisms.^[@bib22]^ Sarcoid granulomas are thought to be formed by a hypersensitive Th1 immune response to certain causative agents.^[@bib1]^ To establish a causative link, agents that putatively cause sarcoidosis must be demonstrated within sarcoid granulomas. In the present study, PAB antibody specific to *P. acnes* that recognize lipoteichoic acid of the plasmalemma reacted with small round bodies within sarcoid granulomas in 88% of lymph node samples and 57% of lung samples. Reactivity to the antibody was not observed in non-sarcoid granulomas, including those from patients with tuberculosis and so-called sarcoid reaction. The high frequency and specificity of *P. acnes* detected within sarcoid granulomas indicates that this indigenous bacterium might be the cause of granuloma formation in many patients with sarcoidosis. *P. acnes* was not detected within sarcoid granulomas in samples from some patients with sarcoidosis, however, suggesting that sarcoidosis has various causes, including noninfectious causes.

In many sarcoid samples in which *P. acnes* was not detected within granulomas, *P. acnes* was also not detected in nongranulomatous areas. It is likely that in some such sarcoid samples, other bacteria, such as *P. granulosum* or *M. tuberculosis*, are the cause of the granuloma formation, because the PAB antibody was specific to *P. acnes* and did not cross-react with these bacteria. *M. tuberculosis* is a suspected cause of sarcoidosis in Western countries.^[@bib8],\ [@bib9],\ [@bib23],\ [@bib24],\ [@bib25]^ In a previous international collaboration study using real-time quantitative PCR, many *P. acnes* genomes were detected in many samples from European patients with sarcoidosis, whereas a few *M. tuberculosis* genomes were detected in samples from some of these patients.^[@bib7]^ In the present study, *P. acnes* was detected within sarcoid granulomas by the PAB antibody in 89% of lymph node samples from German patients. *P. acnes* may cause sarcoidosis more frequently than does *M. tuberculosis*, even in European patients. Ishige *et al*^[@bib26]^ found many *P. granulosum* genomes in 3 of 15 Japanese patients with sarcoidosis. None of the three patients with *P. granulosum* had *P. acnes* genomes in their biopsy samples. They also found a few *M. tuberculosis* genomes in 3 of 15 patients with sarcoidosis. The three patients with *M. tuberculosis* also had many *P. acnes* genomes in their biopsy samples. Thus, *P. granulosum* is more likely than *M. tuberculosis* to be the cause of sarcoidosis in patients without *P. acnes* detected within granulomas by the PAB antibody.

Another possible explanation for the failure to detect *P. acnes* within granulomas of some sarcoid samples is that the *P. acnes* antigens were completely degraded by the granuloma cells, which possess a greater capacity for intracellular digestion than macrophages.^[@bib27],\ [@bib28]^ In the present study, PAB antibody reactivity was observed more frequently in immature granulomas than in mature granulomas. The *P. acnes* antigen may have thus been degraded and abolished in the granuloma cells as the granuloma matured. Indeed, even in the same samples, reactivity was found in some granulomas but was totally absent in other granulomas. Such an inhomogeneous distribution of granulomas with PAB antibody reactivity may have contributed to the failure to detect *P. acnes* within granulomas, especially in small samples with few granulomas. The inhomogeneous distribution might explain the finding that the frequency (48%) of granulomas with PAB antibody reactivity in samples obtained by transbronchial lung biopsy was significantly lower than that (74%) in samples obtained by video-assisted thoracic surgery. Surgically-resected samples are larger and include more granulomas than the biopsy samples. Differences in the size between samples obtained by surgery and biopsy may also explain why PAB antibody reactivity was observed in alveolar macrophages in some (12%) of the sarcoid biopsy samples with no PAB antibody reactivity within the granulomas.

The PAB antibody obtained by immunization with a serotype II strain (ATCC 11828) reacted with lipoteichoic acid from both serotype I and II strains of *P. acnes*. We confirmed that the PAB antibody reacted with both serotype I and II *P. acnes* on formalin-fixed and paraffin-embedded liver tissues of rats injected intravenously by either serotype I or II *P. acnes* (data not shown). Furukawa *et al*^[@bib20]^ reported that clinical isolates from sarcoid tissues are either serotype I (70%) or serotype II (30%), and only serotype I isolates invade cells. Although the present study does not provide information about *P. acnes* serotypes within sarcoid granulomas, we conclude that the failure to detect *P. acnes* in some sarcoid samples is not caused by potential differences in the *P. acnes* serotype found in sarcoid granulomas.

The large-spheroidal acid-fast bodies that reacted with both PAB and TIG antibodies in sinus macrophages of the lymph nodes were consistent with so-called Hamazaki--Wesenberg bodies. Hamazaki--Wesenberg bodies frequently appear in sarcoid lymph nodes although these bodies are not specific to sarcoidosis.^[@bib29],\ [@bib30],\ [@bib31]^ In the present study, Hamazaki--Wesenberg bodies were found in 50% of sarcoid samples and 15% of non-sarcoid samples. Moscovic^[@bib29]^ suggested that Hamazaki--Wesenberg bodies are mycobacterial [L]{.smallcaps}-forms based on morphological studies. Alavi and Moscovic^[@bib32]^ reported that Hamazaki--Wesenberg bodies reacted with World Health Organization monoclonal antibodies (TB68 and TB71) to *M. tuberculosis* complex, although they did not examine the specificities of the antibodies used in the study. In the present study, the PAB and TIG antibodies that reacted with Hamazaki--Wesenberg bodies found in both sarcoid and non-sarcoid samples were specific to *P. acnes* and did not react with the *M. tuberculosis* complex. Moreover, immunoelectron microscopy revealed that immunoreactive products with PAB antibody and TIG antibody were differentially distributed in the outer and inner areas of the Hamazaki--Wesenberg bodies, respectively. The different localization of the reaction products of the two *P. acnes*-specific antibodies suggests that the reactivity of these antibodies with Hamazaki--Wesenberg bodies was not caused by a nonspecific reaction. Thus, we conclude that Hamazaki--Wesenberg bodies are structures derived from *P. acnes*.

Cell membrane-bound lipoteichoic acid detected by the PAB antibody and ribosome-bound trigger factor detected by the TIG antibody were both found in the Hamazaki--Wesenberg bodies, preserving the original distribution pattern (plasmalemmal and protoplasmic localization, respectively) of these bacterial components in terms of the morphological structure of the bacterium. A mixed distribution of these differentially-distributed bacterial components in identical areas was not observed in the bodies. These immunoelectron-microscopic findings suggest that Hamazaki--Wesenberg bodies might not be phagolysosomally-degraded products of *P. acnes*, but rather intact forms of intracellular bacteria. Furthermore, conventional electron microscopy revealed that these bodies lack a cell-wall structure and occasionally exhibit protrusions from the body. Further studies are needed to elucidate the nature of Hamazaki--Wesenberg bodies in connection with *P. acnes*.

Intracellular small round bodies detected by PAB antibody were also observed in nongranulomatous areas of sarcoid and non-sarcoid samples. In sarcoid lungs, alveolar macrophages filled with many small round bodies might contribute to granuloma formation in the lung parenchyma because such macrophages were occasionally found in granulomatous inflammation or within immature granulomas of the lungs. In sarcoid lymph nodes, a cluster of granuloma-free paracortical macrophages filled with many small round bodies might be an early focal site of sarcoid granuloma because such macrophages were occasionally found within sarcoid granulomas of the lymph nodes. Although intracellular *P. acnes* was not specific to sarcoid samples, the frequency was higher and the extent more prominent in sarcoid samples than in non-sarcoid samples.

*P. acnes* is the most common commensal bacterium in the lungs and lymph nodes of subjects without sarcoidosis.^[@bib33]^ *P. acnes* is found in 21% of non-sarcoid lymph nodes by bacterial culture^[@bib13]^ and 15% of non-sarcoid lymph nodes by PCR.^[@bib26]^ In the non-sarcoid samples examined in the present study, we found *P. acnes* in 18% of lung samples and 22% of lymph node samples. Occasional detection of *P. acnes* in nongranulomatous areas of the lungs and lymph nodes from non-sarcoid patients suggests that host factors may be more critical than agent factors in the etiology of sarcoidosis.

A particular protein, referred to as a trigger factor, from *P. acnes* causes a cellular immune response in some sarcoid patients, but not in subjects without sarcoidosis.^[@bib10]^ The *P. acnes* trigger-factor protein induces pulmonary granulomas in mice sensitized with the protein and adjuvant, but only in mice with latent *P. acnes* infection in their lungs.^[@bib16]^ This pathogenesis was confirmed by further experiments using mice sensitized with *P. acnes* and adjuvant, in which the eradication of *P. acnes* by antibiotics prevented granulomas in this experimental model.^[@bib34]^ The results of this experimental model of sarcoidosis might explain the recently reported effectiveness of tetracyclines for treating sarcoidosis.^[@bib35],\ [@bib36],\ [@bib37],\ [@bib38]^

In the present study, we developed novel *P. acnes*-specific monoclonal antibodies that can detect *P. acnes* in formalin-fixed paraffin-embedded tissue sections. The high frequency and specificity of *P. acnes* detected by PAB antibody within sarcoid granulomas suggests an etiologic link between sarcoidosis and this indigenous bacterium. The PAB antibody may be useful for diagnosing sarcoidosis caused by *P. acnes*, when the reactivity is detected in idiopathic granulomas.
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![Western blot analysis for reactivity of the anti-*P. acnes* antibodies. Western blot analysis with PAB and TIG antibodies was performed using sonicated whole-cell lysate (lanes 1--10) with the appropriate positive control samples. Lane 1, serotype I *P. acnes* (ATCC 6919); lane 2, serotype I *P. acnes* (ATCC 11827); lane 3, serotype II *P. acnes* (ATCC 11828); lane 4, serotype I *P. acnes* (clinical isolate S4); lane 5, serotype II *P. acnes* (clinical isolate S7); lane 6, *P. granulosum*; lane 7, *P. avidum*; lane 8, *M. tuberculosis*; lane 9, *M. avium*; and lane 10, *M. intracellulare*. Positive control samples for the PAB antibody were lipoteichoic acid purified from serotype I (lane 11) and serotype II (lane 12) of *P. acnes*. Positive control samples for the TIG antibody were recombinant trigger-factor protein from the whole-genome sequence of *P. acnes* serotype I (lane 13) and serotype II (lane 14).](modpathol201280f1){#fig1}

![*P. acnes* within sarcoid granulomas of the lungs. Hematoxylin and eosin staining (left) and immunostaining with PAB antibody (right) are shown pairwise for three different video-assisted thoracic surgery samples of the lungs from sarcoid patients (original magnification, × 400). A higher magnification of the positive reaction products indicated by the red arrows is shown in each inset. In the granulomatous alveolitis lesion (**a**, **b**), some swollen macrophages of the immature granuloma were filled with many small round bodies detected by PAB antibody. In the granuloma lesion surrounded by prominent inflammatory cell infiltration (**c**, **d**), such small round bodies were detected not only in the granuloma cells but also in some of the inflammatory cells (black arrows). In a mature granuloma (**e**, **f**), a few granuloma cells with degraded forms of the small round bodies were sparsely distributed within the granulomas.](modpathol201280f2){#fig2}

![*P. acnes* within sarcoid granulomas of the lymph nodes. Hematoxylin and eosin staining (left) and immunostaining with PAB antibody (right) are shown pairwise for two Japanese samples (**a**, **b**, and **c**, **d**) and one German sample (**e**, **f**) of lymph nodes from patients with sarcoidosis (original magnification, × 1000). A higher magnification of the positive reaction products indicated by the red arrows is shown in each inset. Many small round bodies were detected within an immature granuloma (**a**, **b**) and a few small round bodies were detected within a mature granuloma (**c**, **d**). Granuloma cells filled with such small round bodies were observed at the rim of a granuloma (**b**, **d**). In many sarcoid granulomas, including in the German samples shown here (**e**, **f**), large spheroidal bodies detected by PAB antibody were sparsely distributed within a mature granuloma.](modpathol201280f3){#fig3}

![*P. acnes* in non-granulomatous areas of the sarcoid and non-sarcoid lungs and lymph nodes. Many macrophages with many small round bodies detected by PAB antibody were found in alveolar spaces adjacent to granulomas (^\*^) and areas of inflammation (indicated by the arrow heads) of many video-assisted thoracic surgery samples from sarcoid patients (**a**). A few such alveolar macrophages were also detected in some lung samples from non-sarcoid patients (**b**). Clusters of macrophages with many small round bodies detected by PAB antibody were found in granuloma-free paracortical areas of the lymph nodes with sarcoid granulomas (**c**). A few paracortical macrophages with many small round bodies detected by PAB antibody were also found in some samples from non-sarcoid patients (**d**). Higher magnification of the positive reaction products indicated by the red arrows is shown in each inset (**a**--**d**). A few large spheroidal bodies detected by PAB antibody, indicated by the black arrow, were occasionally observed in alveolar macrophages of the sarcoid lungs (**e**). Such a large spheroidal body also reacted with TIG antibody (**f**), as indicated by the black arrow and was acid-fast with Fite staining (f, inset). Original magnification: **a**--**b**, × 400; **c**--**d**, × 200; **e**--**f**, × 1000.](modpathol201280f4){#fig4}

![Immunofluorescence double-staining to phenotype the *P. acnes*-positive cells in non-granulomatous areas of sarcoid lungs and lymph nodes. Green signal (FITC): PAB antibody; red signals (TRITC): anti-CD68 antibody (**a**, **c**, **e**), anti-fascin antibody (**b**, **d**, **f**). Results of double-staining are merged in all pictures. In the sarcoid lung, all of the *P. acnes* signals overlapped (yellow) with CD68-positive alveolar macrophages (**a**), whereas the fascin-positive alveolar dendritic cells did not contain small round bodies detected by PAB antibody (**b**). In the paracortical area of the sarcoid lymph node, small round body detected by PAB antibody were found in the CD68-positive macrophages (**c**), but not in the fascin-positive dendritic cells (**d**). In the sinus of the sarcoid lymph node, Hamazaki-Wesenberg bodies detected by PAB antibody overlapped with CD68-positive macrophages (**e**), but not with the fascin-positive dendritic cells (**f**). Original magnification: **a**--**b**, × 400; **c**--**f**, × 1000.](modpathol201280f5){#fig5}

![Large-sized acid-fast bodies detected by PAB and TIG monoclonal antibodies in sarcoid lymph nodes. In this lymph node sample from a Japanese patient with sarcoidosis, many large-sized yellow-brown bodies, as indicated by the arrows, were observed with hematoxylin and eosin staining in hyperplastic sinuses (**a**). These bodies were strongly acid-fast with Fite staining (**a**, inset). Electron-microscopy of the same sample revealed typical features of Hamazaki-Wesenberg bodies (**b**). This sarcoid lymph node sample was examined by immunohistochemistry using PAB antibody (**c**, **d**) and TIG antibody (**e**, **f**) with light microscopy and electron microscopy. The Hamazaki-Wesenberg bodies reacted with PAB antibody (**c**) and abundant reaction products of the antibody, as indicated by the arrows, located along the outer margin of the body (**d**). The Hamazaki-Wesenberg bodies also reacted with TIG antibody (**e**) and spotty reaction products of the antibody, as indicated by the arrows, located throughout the inner areas of the body (**f**). Original magnification: **a**, **c**, and **e**, × 1000. Scale bars indicate 2 *μ*m in **b**, **d**, and **f**.](modpathol201280f6){#fig6}

![Protrusions from Hamazaki-Wesenberg bodies in sarcoid lymph nodes. Electron-microscopic analysis revealed Hamazaki-Wesenberg bodies with protrusions in sinus macrophages of two different sarcoid lymph nodes. Multiple protrusions (**a**) are represented by fused bodies, with or without a central osmiophilic core, surrounded by a discontinuous limiting membrane. One-by-one protrusions (**b**) are represented by a large spheroidal body with two fused central cores (¶) and a separated core (^\*^) linked together with a small round body (indicated by the black arrow). Adjacent to and separated from this small round body, another similar-shaped small round body (indicated by the arrowhead) was observed, which might reveal how these small round bodies are derived from the Hamazaki-Wesenberg body. Scale bars indicate 2 *μ*m.](modpathol201280f7){#fig7}

###### Specificity of the PAB and TIG antibodies examined by western blot

  *Bacteria*                                  *Strain*         *Reactivity of*  
  ------------------------------------- --------------------- ----------------- ----
  *Propionibacterium acnes*                   ATCC 6919              \+          \+
  *Propionibacterium acnes*                  ATCC 11827              \+          \+
  *Propionibacterium acnes*                  ATCC 11828              \+          \+
  *Propionibacterium acnes*              Clinical isolate S4         \+          \+
  *Propionibacterium acnes*              Clinical isolate S7         \+          \+
  *Propionibacterium granulosum*             ATCC 25564               −          −
  *Propionibacterium avidum*                 ATCC 25577               −          −
  *Propionibacterium lymphophilum*           ATCC 27520               −          −
  *Propionibacterium propionicum*            ATCC 14157               −          −
  *Propionibacterium freudenreichii*          ATCC 6207               −          −
  *Propionibacterium jensenii*                ATCC 4868               −          −
  *Propionibacterium thoenii*                 ATCC 4874               −          −
  *Propionibacterium acidipropionici*        ATCC 25562               −          −
  *Mycobacterium bovis*                      ATCC 19274               −          −
  *Mycobacterium tuberculosis*               ATCC 25177               −          −
  *Mycobacterium avium*                      ATCC 25291               −          −
  *Mycobacterium intracellulare*             ATCC 13950               −          −
  *Actinomyces pyogenes*                     ATCC 19411               −          −
  *Bifidobacterium bifidum*                  ATCC 29521               −          −
  *Lactobacillus acidophilus*                 ATCC 4356               −          −
  *Bacteroides fragilis*                     ATCC 25285               −          −
  *Fusobacterium nucleatum*                  ATCC 25586               −          −
  *Listeria monocytogenes*                   ATCC 15313               −          −
  *Nocardia asteroides*                      ATCC 19247               −          −
  *Staphylococcus aureus*                    ATCC 25923               −          −
  *Escherichia coli*                         ATCC 11775               −          −
  *Pseudomonas aeruginosa*                   ATCC 27853               −          −
  *Klebsiella pneumoniae*                    ATCC 13884               −          −

###### Frequency and localization of *P. acnes* detected by PAB antibody in sarcoid and non-sarcoid lung samples

  *Disease*                                                      *Sampling method*    *Total number of samples*  *Number (%) of samples with P. acnes detected in:*             
  -------------------------------------------------------------- ------------------- --------------------------- ---------------------------------------------------- --------- ---------
  Sarcoidosis                                                    VATS                            27              20 (74)                                              22 (81)   14 (52)
                                                                 TBLB                            50              24 (48)                                              18 (36)   14 (28)
  Tuberculosis                                                   VATS                            12              0                                                    0         3 (25)
                                                                 TBLB                             5              0                                                    0         0
  Lung cancer with sarcoid reaction[a](#t2-fn2){ref-type="fn"}   Operation                       10              0                                                    0         4 (40)
  Lung cancer[b](#t2-fn3){ref-type="fn"}                         Operation                       18              ---                                                  ---       7 (39)
                                                                 TBLB                            26              ---                                                  ---       0
  IIPs[c](#t2-fn4){ref-type="fn"}                                VATS                             5              ---                                                  0         1 (20)
                                                                 TBLB                            11              ---                                                  0         2 (18)
  Chronic HP                                                     VATS                             8              ---                                                  0         1 (13)
                                                                 TBLB                            15              ---                                                  0         0

IIPs: idiopathic interstitial pneumonia; HP: hypersensitivity pneumonitis; VATS: video-assisted thoracic surgery; TBLB: transbronchial lung biopsy.

Tissue samples with non-caseating epithelioid-cell granulomas around the cancer lesion were examined. These lung cancer patients had no symptoms or signs of systemic sarcoidosis.

Cancer-free lung tissue sections were selected from operation materials for the study. All pieces of TBLB samples, including cancer lesions, were examined for the study.

IIPs include usual interstitial pneumonia, non-specific interstitial pneumonia, and organizing pneumonia.

###### Frequency and localization of *P. acnes* detected by PAB antibody in sarcoid and non-sarcoid lymph node samples

  *Disease*                                      *Location*                                *Total number of samples*  *Number (%) of samples with P. acnes detected in:*             
  ---------------------------------------------- ---------------------------------------- --------------------------- ---------------------------------------------------- --------- ---------
  Sarcoidosis                                    Mediastinal                                          44              38 (86)                                              13 (30)   26 (59)
                                                 Mediastinal[a](#t3-fn1){ref-type="fn"}               38              34 (89)                                              8 (21)    19 (50)
                                                 Superficial                                          37              33 (89)                                              5 (14)    15 (41)
  Tuberculosis                                   Mediastinal                                           3              0                                                    0         0
                                                 Mediastinal[a](#t3-fn1){ref-type="fn"}                8              0                                                    0         1 (13)
                                                 Superficial                                          17              0                                                    2 (12)    1 (6)
  Sarcoid reaction[b](#t3-fn2){ref-type="fn"}    Mediastinal                                           8              0                                                    1 (13)    5 (63)
                                                 Perigastric                                          16              0                                                    4 (25)    3 (19)
  Lung cancer[c](#t3-fn3){ref-type="fn"}         Mediastinal                                          18              ---                                                  0         1 (6)
                                                 Mediastinal[a](#t3-fn1){ref-type="fn"}               18              ---                                                  0         5 (28)
  Gastric cancer[c](#t3-fn3){ref-type="fn"}      Perigastric                                          20              ---                                                  3 (15)    0
  Colorectal cancer[c](#t3-fn3){ref-type="fn"}   Mesenteric                                           20              ---                                                  6 (30)    6 (30)
  Reactive lymphadenitis                         Superficial                                          26              ---                                                  2 (8)     2 (8)
  Necrotizing lymphadenitis                      Superficial                                          11              ---                                                  0         0

Samples from German patients.

All samples with sarcoid reaction were obtained from cancer-free regional lymph nodes from 8 patients with lung cancer and 16 patients with gastric cancer. None of these cancer patients had symptoms or signs of systemic sarcoidosis.

Cancer-free regional lymph nodes from cancer patients were used for the study.

###### Correlation between *P. acnes* detected in granulomas and non-granulomatous areas in sarcoid samples

  *Organ*      *Sample category*   *Localization of P. acnes in non-granulomatous area*                              *Detection status of P. acnes within granulomas*  
  ------------ ------------------- -------------------------------------------------------------------------------- -------------------------------------------------- ---------
  Lung         VATS                Total number of samples                                                                                  20                             7
                                   Number (%) of samples with *P. acnes* in alveolar macrophages                                         13 (65%)                          0
               TBLB                Total number of samples                                                                                  24                            26
                                   Number (%) of samples with *P. acnes* in alveolar macrophages                                         11 (46%)                       3 (12%)
  Lymph node   Japan               Total number of samples                                                                                  71                            10
                                   Number (%) of samples with *P. acnes* in paracortical macrophages                                     18 (25%)                          0
                                   Number (%) of samples with Hamazaki-Wesenberg bodies detected by PAB antibody                         38 (54%)                       2 (20%)
               Germany             Total number of samples                                                                                  34                             4
                                   Number (%) of samples with *P. acnes* in paracortical macrophages                                     8 (24%)                           0
                                   Number (%) of samples with Hamazaki--Wesenberg bodies detected by PAB antibody                        19 (56%)                          0

VATS: video-assisted thoracic surgery; TBLB: transbronchial lung biopsy.
